OSE Immunotherapeutics Statistics

Total Valuation

EPA:OSE has a market cap or net worth of EUR 126.43 million. The enterprise value is 155.81 million.

Market Cap	126.43M
Enterprise Value	155.81M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:OSE has 21.87 million shares outstanding. The number of shares has increased by 29.34% in one year.

Current Share Class	n/a
Shares Outstanding	21.87M
Shares Change (YoY)	+29.34%
Shares Change (QoQ)	+0.90%
Owned by Insiders (%)	21.19%
Owned by Institutions (%)	1.00%
Float	16.45M

Valuation Ratios

The trailing PE ratio is 3.91 and the forward PE ratio is 9.97.

PE Ratio	3.91
Forward PE	9.97
PS Ratio	1.51
PB Ratio	1.98
P/TBV Ratio	1.98
P/FCF Ratio	2.61
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.12, with an EV/FCF ratio of 3.22.

EV / Earnings	4.16
EV / Sales	1.87
EV / EBITDA	3.12
EV / EBIT	3.56
EV / FCF	3.22

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.72.

Current Ratio	3.46
Quick Ratio	1.03
Debt / Equity	0.72
Debt / EBITDA	0.92
Debt / FCF	0.95
Interest Coverage	7.81

Financial Efficiency

Return on equity (ROE) is 86.29% and return on invested capital (ROIC) is 30.59%.

Return on Equity (ROE)	86.29%
Return on Assets (ROA)	26.53%
Return on Invested Capital (ROIC)	30.59%
Return on Capital Employed (ROCE)	42.16%
Revenue Per Employee	1.60M
Profits Per Employee	720,096
Employee Count	55
Asset Turnover	0.81
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.81% in the last 52 weeks. The beta is 0.82, so EPA:OSE's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+15.81%
50-Day Moving Average	6.46
200-Day Moving Average	7.48
Relative Strength Index (RSI)	34.76
Average Volume (20 Days)	130,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:OSE had revenue of EUR 83.44 million and earned 37.45 million in profits. Earnings per share was 1.48.

Revenue	83.44M
Gross Profit	83.44M
Operating Income	43.73M
Pretax Income	39.83M
Net Income	37.45M
EBITDA	49.26M
EBIT	43.73M
Earnings Per Share (EPS)	1.48

Full Income Statement

Balance Sheet

The company has 16.75 million in cash and 46.13 million in debt, giving a net cash position of -29.39 million or -1.34 per share.

Cash & Cash Equivalents	16.75M
Total Debt	46.13M
Net Cash	-29.39M
Net Cash Per Share	-1.34
Equity (Book Value)	63.81M
Book Value Per Share	2.92
Working Capital	49.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 48.44 million and capital expenditures -77,000, giving a free cash flow of 48.36 million.

Operating Cash Flow	48.44M
Capital Expenditures	-77,000
Free Cash Flow	48.36M
FCF Per Share	2.21

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 52.41% and 44.88%.

Gross Margin	100.00%
Operating Margin	52.41%
Pretax Margin	47.74%
Profit Margin	44.88%
EBITDA Margin	59.03%
EBIT Margin	52.41%
FCF Margin	57.96%

Dividends & Yields

EPA:OSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.34%
Shareholder Yield	-29.34%
Earnings Yield	29.62%
FCF Yield	38.25%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:OSE has an Altman Z-Score of 4.18.

Altman Z-Score	4.18
Piotroski F-Score	n/a